These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use. Varga J; Griffin R; Newman JH; Jimenez SA J Rheumatol; 1991 Feb; 18(2):259-63. PubMed ID: 2023221 [TBL] [Abstract][Full Text] [Related]
9. [Eosinophilia-myalgia syndrome following administration of a L-tryptophan preparation]. Frick P; Frey R Schweiz Med Wochenschr; 1990 Nov; 120(44):1633-5. PubMed ID: 2251478 [TBL] [Abstract][Full Text] [Related]
10. Scleroderma and L-tryptophan: a possible explanation of the eosinophilia-myalgia syndrome. Connolly SM; Quimby SR; Griffing WL; Winkelmann RK J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):451-7. PubMed ID: 2212143 [TBL] [Abstract][Full Text] [Related]
11. [Eosinophilia-myalgia syndrome with fasciitis and interstitial myositis after L-tryptophan administration]. Bartz-Bazzanella P; Genth E; Pollmann HJ; Schröder JM; Völker A Z Rheumatol; 1992; 51(1):3-13. PubMed ID: 1574934 [TBL] [Abstract][Full Text] [Related]
12. Scleroderma-like fasciitis without eosinophilia after L-tryptophan ingestion. Schlessel K; Greenwald R; Hirschfield L J Rheumatol; 1991 May; 18(5):779-82. PubMed ID: 1865433 [TBL] [Abstract][Full Text] [Related]
16. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. Hertzman PA; Blevins WL; Mayer J; Greenfield B; Ting M; Gleich GJ N Engl J Med; 1990 Mar; 322(13):869-73. PubMed ID: 2314421 [TBL] [Abstract][Full Text] [Related]
17. [Eosinophilia-myalgia syndrome. Clinical aspects and follow-up of 10 patients]. Mensing H; Schallreuter KU; Senff H; Steinkraus V Hautarzt; 1992 Jul; 43(7):436-40. PubMed ID: 1506202 [TBL] [Abstract][Full Text] [Related]